Professor of Drug Delivery and Targeting: Pharmaceutical Nanobiotechnology
Email: yomidi@tbzmed.ac.ir
Editor-in-chief of BioImpacts (BI)
Editorial Board of: Daru; Journal of Ophthalmic and Vision Research;
International Journal for Biotechnology and Molecular Biology Research
Member of: Iranian Academy of Medical Sciences
Full CV |
Professor Yadollah Omidi obtained his pharmacy doctorate (Pharm.D.) degree from Tabriz University of Medical Sciences (TUOMS), Tabriz, Iran (1991), and his Ph.D. degree in the field of brain drug delivery and targeting, “Blood-brain barrier: studies of novel cell-based in vitro models and carrier-mediated transporters” from Cardiff University, Cardiff, UK (2003). From Dec. 2002 to July 2004, he worked as a postdoctoral research associate, studying gene-based nanomedicines and toxicogenomics at the Welsh School of Pharmacy, Cardiff University.
In 2005, Dr. Omidi founded the Research Center for Pharmaceutical Nanotechnology (RCPN) at TUOMS - the first national center for nanomedicine researches. Under his directorship, RCPN has been ranked as the national center of excellence for pharmaceutical/biomedical researches (2008-2011, 2013). In 2008, he founded the School of Advanced Biomedical Sciences at TUOMS. He acted as the director of RCPN until July 2011 when he moved to the US to work at the University of Pennsylvania (UPenn). His research activities are focused on different areas of pharmaceutical sciences particularly targeted therapeutics such as multifunctional nanomedicines and theranostics. As of 2003, he has published over 180 papers in peer-reviewed international journals such as Brain Res, Pharm Res, J Drug Target, J Controlled Release, Int J Nanomed, J Pharm Sci, J Biomed Nanotech, Biodrugs, etc. Dr. Omidi is the author of 18 book chapters.
His works have been cited over 5300 times with the h-index of 40 and i10-index of 116. He has over 20 years of experience in pharmacy and medical schools, teaching different subjects (Pharmaceutics, Biopharmaceutics, Pharmacogenetics, Pharmaceutical Nanotechnology, and Pharmaceutical Biotechnology) and supervising M.Sc., Pharm.D., M.D. and Ph.D. students. In 2011, Dr. Omidi founded “
BioImpacts” which is an international peer-review multidisciplinary access free-publish free journal for publication of biomedical and pharmaceutical researches - a publication platform for bench-to-bedside researches. Professor Omidi also acts as the editorial board of several journals, including
Biologicals, BMC Pharmacology and Toxicology.
In 2011, he joined the
Ovarian Cancer Research Center (OCRC), Perelman School of Medicine, University of Pennsylvanian (Philadelphia, USA) as a Visiting Associate Professor to undertake a translational research towards development of multifunctional nanomedicines and theranostics for targeted therapy of ovarian cancer with a particular focus on targeting of the tumor microenvironment.
Follow Professor Y. Omidi's publications through Google Scholar;
PubMed;
ISI Web of Knowledge Scopus ID: 6508117068 ORCID: 0000-0003-0067-2475 ResearcherID: E-8452-2013
.
His research interests include:
- Molecular pharmaceuticals for crossing biological barriers (BBB, BOB)
- Multifunctional nanomedicines and multimodal theranostics
- Molecular Therapy (mAbs, bispecific antibody scaffolds, molecular vaccines)
- Gene/cell therapy and regenerative medicine
- Nanobiosensors for early detection of diseases
Selected Book Chapters
Omidi Y. and Davaran, Impacts of biodegradable polymers - towards biomedical applications, in: A Handbook of Biopolymers: Synthesis, Degradation and Applications, Sharma, S., Royal Society of Chemistry (RSC), (Scheduled 2011).
Khani S., Barar J., Movafeghi A. and Omidi Y., Production of anticancer secondary metabolites: impacts of bioprocess engineering, in: Biotechnological production of plant secondary metabolites, Orhan I. (ed.), Bentham Science Publisher (Scheduled 2011).
Omidi Y., Barar J., Hamzeiy H., Nanomedicines Impacts in Ocular Delivery and Targeting, in: Nanotechnology in human health care. (ISBN: 981426721X),Sahoo, S. (ed), Pan Stanford Publishing, Singapore, (Scheduled 2010).
Omidi, Y., Gumbleton, M., “Biological Membranes and Barriers”, in: Biomaterials for Delivery and Targeting of Proteins Nucleic Acids, Mahato, R.I. (ed.), CRC Press, New York, pp. 232-274,(2005).
Selected papers
Jaymand M, Hatamzadeh M, Omidi Y. Modification of polythiophene by the incorporation of processable polymeric chains: Recent progress in synthesis and applications. Progress in Polymer Science. 2015.
Barar J, Kafil V, Majd MH, Barzegari A, Khani S, Johari-Ahar M, et al. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells. Journal of Nanobiotechnology. 2015;13.
Kafil V, Eskandani M, Omidi Y, Nazemiyeh H, Barar J. Abietane diterpenoid of Salvia Sahendica Boiss and Buhse potently inhibits MCF-7 breast carcinoma cells by suppression of PI3K/AKT pathway. RSC Advances. 2015;5:18041-50.
Johari-Ahar M, Rashidi M-R, Barar J, Agaie M, Mohammadnejad D, Ramazani A, et al. An ultra-sensitive impedimetric immunosensor for detection of serum antigen CA-125 in ovarian cancer patients. Nanoscale. 2015;7:3768-79.
Zhao A, Tohidkia MR, Siegel DL, Coukos G, Omidi Y. Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy. Critical reviews in biotechnology. 2014 (0):1-14.